BackPanbela Therapeutics Overview

Panbela Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PBLA.

Quarterly EBIT

-$14.33M
↑ 8.68% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$44.31M
↓ 40.42% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin